When does the patent on Orgovyx (relugolix) expire?
Orgovyx (relugolix) is protected by multiple patents, so the “patent expiry” date depends on which specific patent you mean (e.g., drug substance vs. formulation, method-of-use, or specific manufacturing claims). DrugPatentWatch tracks these individual patent timelines rather than giving one single expiry date for the whole product. [1]
To find the exact expiry for each relevant patent, check Orgovyx’s listing on DrugPatentWatch and look at the “patent expiry” or “estimated expiration” fields for each patent in the portfolio. [1]
Why the expiry date can vary by source (and by patent number)
Different patents covering Orgovyx can expire in different years, and some entries may reflect:
- the original patent term,
- later adjustments or priority-based calculations,
- “expected” vs. legally verified expiration dates,
- country-specific patent grants (US vs. other jurisdictions). [1]
For that reason, the most accurate answer is tied to the specific patent(s) in force that cover Orgovyx in the market you care about. [1]
Can generics or biosimilars launch before every Orgovyx patent ends?
In many cases, generic competition can become possible while some secondary patents are still active, depending on how regulators treat each patent and whether the generic manufacturer can “carve out” or design around certain claims. The exact timing again depends on the specific patent set and the jurisdiction. [1]
Where to verify the exact Orgovyx patent expiry date(s)
Use DrugPatentWatch’s Orgovyx page to identify the specific patents and their listed expiration dates. [1]
Source
[1] https://www.drugpatentwatch.com/